Giovannoni G, et al. Treatment outcomes of daclizumab in patients at high risk of transitioning to secondary progressive multiple sclerosis in DECIDE. EAN 2107, O2113.
Aios neurochirurgie ontwikkelt succesvolle apps
jan 2011
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen